Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Operating Expenses (2016 - 2025)

Historic Operating Expenses for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $101.1 million.

  • AtriCure's Operating Expenses rose 735.26% to $101.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.5 million, marking a year-over-year increase of 1237.37%. This contributed to the annual value of $387.5 million for FY2024, which is 1849.36% up from last year.
  • As of Q3 2025, AtriCure's Operating Expenses stood at $101.1 million, which was up 735.26% from $107.7 million recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Operating Expenses peaked at $107.7 million during Q2 2025, and registered a low of -$46.4 million during Q3 2021.
  • In the last 5 years, AtriCure's Operating Expenses had a median value of $81.2 million in 2023 and averaged $76.9 million.
  • In the last 5 years, AtriCure's Operating Expenses tumbled by 20477.83% in 2021 and then soared by 25596.75% in 2022.
  • Over the past 5 years, AtriCure's Operating Expenses (Quarter) stood at $67.5 million in 2021, then rose by 2.56% to $69.2 million in 2022, then rose by 27.78% to $88.5 million in 2023, then increased by 21.09% to $107.1 million in 2024, then fell by 5.62% to $101.1 million in 2025.
  • Its Operating Expenses stands at $101.1 million for Q3 2025, versus $107.7 million for Q2 2025 and $98.6 million for Q1 2025.